BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967
15 results:

  • 1. Is the radiomics-clinical combined model helpful in distinguishing between pancreatic cancer and mass-forming pancreatitis?
    Qu W; Zhou Z; Yuan G; Li S; Li J; Chu Q; Zhang Q; Xie Q; Li Z; Kamel IR
    Eur J Radiol; 2023 Jul; 164():110857. PubMed ID: 37172441
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
    Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
    Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutations in the Occurrence and Treatment of pancreatic cancer.
    Zhu Z; Xiao S; Hao H; Hou Q; Fu X
    Curr Top Med Chem; 2019; 19(23):2176-2186. PubMed ID: 31456520
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.
    Athuluri-Divakar SK; Vasquez-Del Carpio R; Dutta K; Baker SJ; Cosenza SC; Basu I; Gupta YK; Reddy MV; Ueno L; Hart JR; Vogt PK; Mulholland D; Guha C; Aggarwal AK; Reddy EP
    Cell; 2016 Apr; 165(3):643-55. PubMed ID: 27104980
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Blood Transfusion in Major Abdominal Surgery for Malignant Tumors: A Trend Analysis Using the National Surgical Quality Improvement Program.
    Ecker BL; Simmons KD; Zaheer S; Poe SL; Bartlett EK; Drebin JA; Fraker DL; Kelz RR; Roses RE; Karakousis GC
    JAMA Surg; 2016 Jun; 151(6):518-25. PubMed ID: 26763765
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation.
    Nussinov R; Tsai CJ; Muratcioglu S; Jang H; Gursoy A; Keskin O
    Expert Rev Proteomics; 2015; 12(6):669-82. PubMed ID: 26496174
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Novel therapeutic targets for pancreatic cancer.
    Tang SC; Chen YC
    World J Gastroenterol; 2014 Aug; 20(31):10825-44. PubMed ID: 25152585
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylation.
    Neel NF; Stratford JK; Shinde V; Ecsedy JA; Martin TD; Der CJ; Yeh JJ
    Mol Cancer Ther; 2014 Jan; 13(1):122-33. PubMed ID: 24222664
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Oncogenesis and the clinical significance of K-ras in pancreatic adenocarcinoma.
    Huang C; Wang WM; Gong JP; Yang K
    Asian Pac J Cancer Prev; 2013; 14(5):2699-701. PubMed ID: 23803017
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Differential involvement of RalA and RalB in colorectal cancer.
    Martin TD; Der CJ
    Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.
    Vigil D; Martin TD; Williams F; Yeh JJ; Campbell SL; Der CJ
    J Biol Chem; 2010 Nov; 285(45):34729-40. PubMed ID: 20801877
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Choline kinase: an important target for cancer.
    Janardhan S; Srivani P; Sastry GN
    Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla.
    Harewood GC; Pochron NL; Gostout CJ
    Gastrointest Endosc; 2005 Sep; 62(3):367-70. PubMed ID: 16111953
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
    Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
    Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.
    Knyrim K; Wagner HJ; Pausch J; Vakil N
    Endoscopy; 1993 Mar; 25(3):207-12. PubMed ID: 8519239
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.